Effects of peripheral κ opioid receptor activation on inflammatory mechanical hyperalgesia in male and female rats

Neuroscience Letters

Volumn 524, Issue 2, 2012, Pages 111-115

  Auh, Q Schick ^a   Ro, Jin Y ^a,b  

^a Kyung Hee University   (South Korea)

^b UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

Inflammation; Kappa opioid receptor; Mechanical hyperalgesia; Peripheral; Sex

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ANALGESIC AGENT; FREUND ADJUVANT; KAPPA OPIATE RECEPTOR;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HYPERALGESIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ADJUVANTS, IMMUNOLOGIC; ANALGESICS; ANIMALS; FEMALE; FREUND'S ADJUVANT; HYPERALGESIA; INFLAMMATION; MALE; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SEX FACTORS;

EID: 84865196107     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.07.018     Document Type: Article

References (41)

1. + channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine. European Journal of Pharmacology 2004, 494(June (2-3)):155-160.
2. Arendt-Nielsen L., Olesen A.E., Staahl C., Menzaghi F., Kell S., Wong G.Y., Drewes A.M. Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain. Anesthesiology 2009, 111(September (3)):616-624.
3. Bastos J.V., Queiroz-Junior C.M., Caliari M.V., Francischi J.N., Pacheco C.M., Maltos K.L. Peripheral kappa opioid receptors activation reduces alveolar bone loss in rats by modulating interleukin-6 and -10. Archives of Oral Biology 2011, 56(June (6)):540-548.
4. Bileviciute-Ljungar I., Spetea M. Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats. European Journal of Pharmacology 2004, 494(June (2-3)):139-146.
5. Binder W., Carmody J., Walker J. Effect of gender on anti-inflammatory and analgesic actions of two kappa-opioids. Journal of Pharmacology and Experimental Therapeutics 2000, 292(January (1)):303-309.
6. Burton M.B., Gebhart G.F. Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation. Journal of Pharmacology and Experimental Therapeutics 1998, 285(May (2)):707-715.
7. Chicre-Alcântara T.C., Torres-Chávez K.E., Fischer L., Clemente-Napimoga J.T., Melo V., Parada C.A., Tambeli C.H. Local kappa opioid receptor activation decreases temporomandibular joint inflammation. Inflammation 2012, 35(February (1)):371-376.
8. Clemente J.T., Parada C.A., Veiga M.C., Gear R.W., Tambeli C.H. Sexual dimorphism in the antinociception mediated by kappa opioid receptors in the rat temporomandibular joint. Neuroscience Letters 2004, 372(December (3)):250-255.
9. Craft R.M. Sex differences in opioid analgesia: from mouse to man. Clinical Journal of Pain 2003, 19(May-June (3)):175-186.
10. Craft R.M., Mogil J.S., Aloisi A.M. Sex differences in pain and analgesia: the role of gonadal hormones. European Journal of Pain 2004, 8(October (5)):397-411.
11. Cunha T.M., Souza G.R., Domingues A.C., Carreira E.U., Lotufo C.M., Funez M.I., Verri W.A., Cunha F.Q., Ferreira S.H. Stimulation of peripheral Kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3Kγ/AKT/nNOS/NO signaling pathway. Molecular Pain 2012, February (8):10.
12. Dionne R.A., Lepinski A.M., Gordon S.M., Jaber L., Brahim J.S., Hargreaves K.M. Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation. Clinical Pharmacology and Therapeutics 2001, 70(July (1)):66-73.
13. Duckett J.W., Cangiano T., Cubina M., Howe C., Cohen D. Intravesical morphine analgesia after bladder surgery. Journal of Urology 1997, 157(April (4)):1407-1409.
14. Eisenach J.C., Carpenter R., Curry R. Analgesia from a peripherally active kappa-opioid receptor agonist in patients with chronic pancreatitis. Pain 2003, 101(January (1-2)):89-95.
15. Fillingim R.B., Gear R.W. Sex differences in opioid analgesia: clinical and experimental findings. European Journal of Pain 2004, 8(October (5)):413-425.
16. Gear R.W., Miaskowski C., Gordon N.C., Paul S.M., Heller P.H., Levine J.D. Kappa-opioids produce significantly greater analgesia in women than in men. Nature Medicine 1996, 2(November (11)):1248-1250.
17. Gear R.W., Gordon N.C., Heller P.H., Paul S., Miaskowski C., Levine J.D. Gender difference in analgesic response to the kappa-opioid pentazocine. Neuroscience Letters 1996, 205(March (3)):207-209.
18. Holtman J.R., Wala E.P. Characterization of antinociceptive effect of oxycodone in male and female rats. Pharmacology, Biochemistry and Behavior 2006, 83:100-108.
19. Joshi S.K., Su X., Porreca F. Gebhart GF kappa-opioid receptor agonists modulate visceral nociception at a novel, peripheral site of action. Journal of Neuroscience 2000, 20(August (15)):5874-5879.
20. Ko M.C., Johnson M.D., Butelman E.R., Willmont K.J., Mosberg H.I., Woods J.H. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics 1999, 291(December (3)):1113-1120.
21. Lomas L.M., Barrett A.C., Terner J.M., Lysle D.T., Picker M.J. Sex differences in the potency of kappa opioids and mixed-action opioids administered systemically and at the site of inflammation against capsaicin-induced hyperalgesia in rats. Psychopharmacology (Berl.) 2007, 191(April (2)):273-285.
22. Mangel A.W., Bornstein J.D., Hamm L.R., Buda J., Wang J., Irish W., Urso D. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 2008, 28(July (2)):239-249.
23. + channels in trigeminal ganglia under an acute muscle pain condition. Neuroscience 2011, April (180):344-352.
24. Obara I., Mika J., Schafer M.K., Przewlocka B. Antagonists of the kappa-opioid receptor enhance allodynia in rats and mice after sciatic nerve ligation. British Journal of Pharmacology 2003, 140(October (3)):538-546.
25. Obara I., Parkitna J.R., Korostynski M., Makuch W., Kaminska D., Przewlocka B., Przewlocki R. Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain. Pain 2009, 141(February (3)):283-291.
26. Pacheco C.M., Queiroz-Junior C.M., Maltos K.L., Caliari M.V., Pacheco D.F., Duarte I.D., Francischi J.N. Crucial role of peripheral kappa-opioid receptors in a model of periodontal disease in rats. Journal of Periodontal Research 2008, 43(December (6)):730-736.
27. Pena-dos-Santos D.R., Severino F.P., Pereira S.A., Rodrigues D.B., Cunha F.Q., Vieira S.M., Napimoga M.H., Clemente-Napimoga J.T. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint. Neuroscience 2009, 163(November (4)):1211-1219.
28. Puehler W., Rittner H.L., Mousa S.A., Brack A., Krause H., Stein C., Schäfer M. Interleukin-1 beta contributes to the upregulation of kappa opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation. Neuroscience 2006, 141(August (2)):989-998.
29. Rivière P.J. Peripheral kappa-opioid agonists for visceral pain. British Journal of Pharmacology 2004, 141(April (8)):1331-1334.
30. Saloman J.L., Niu K.Y., Ro J.Y. Activation of peripheral delta-opioid receptors leads to anti-hyperalgesic responses in the masseter muscle of male and female rats. Neuroscience 2011, 190(September):379-385.
31. Sehgal N., Smith H.S., Manchikanti L. Peripherally acting opioids and clinical implications for pain control. Pain Physician 2011, 14(May-June (3)):249-258.
32. Sengupta J.N., Snider A., Su X., Gebhart G.F. Effects of kappa opioids in the inflamed rat colon. Pain 1999, 79(February (2-3)):175-185.
33. Stein C., Millan M.J., Shippenberg T.S., Peter K., Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. Journal of Pharmacology and Experimental Therapeutics 1989, 248(March (3)):1269-1275.
34. Szarka L.A., Camilleri M., Burton D., Fox J.C., McKinzie S., Stanislav T., Simonson J., Sullivan N., Zinsmeister A.R. Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome. Clinical Gastroenterology and Hepatology 2007, 5(November (11)):1268-1275.
35. Tao Y.M., Li Q.L., Zhang C.F., Xu X.J., Chen J., Ju Y.W., Chi Z.Q., Long Y.Q., Liu J.G. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential. European Journal of Pharmacology 2008, 584(April (2-3)):306-311.
36. Tegeder I., Meier S., Burian M., Schmidt H., Geisslinger G., Lötsch J. Peripheral opioid analgesia in experimental human pain models. Brain 2003, 126(May (Pt 5)):1092-1102.
37. Vadivelu N., Mitra S., Hines R.L. Peripheral opioid receptor agonists for analgesia: a comprehensive review. Journal of Oncology Management 2011, 7(January-February (1)):55-68.
38. Vanderah T.W. Delta and kappa opioid receptors as suitable drug targets for pain. Clinical Journal of Pain 2010, 26(January (Suppl. 10)):S10-S15.
39. Vanderah T.W., Largent-Milnes T., Lai J., Porreca F., Houghten R.A., Menzaghi F., Wisniewski K., Stalewski J., Sueiras-Diaz J., Galyean R., Schteingart C., Junien J.L., Trojnar J., Novel Rivière P.J. D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. European Journal of Pharmacology 2008, 583(March (1)):62-72.
40. 2): a peripheral efficacious kappa opioid agonist with unprecedented selectivity. Journal of Pharmacology and Experimental Therapeutics 2004, 310(July (1)):326-333.
41. Zhang Y., Bai G., Ro J.Y. Differential regulation of peripheral opioid receptor subtype expressions following inflammation in the rat masseter muscle. Society for Neuroscience Meeting 2005.